Meet Our Scientific Board

SMARTfit is conducting clinical study activity in several high value areas within the medical market where SMARTfit’s unique value proposition which includes Baseline Measurement, Custom Protocol Development and Session/Progress Reporting in both Diagnostic and Treatment pathways promises to offer patients meaningful gains in quality of life measures.

Systems have recently been installed at Rancho Los Amigos Rehabilitation Hospital, and Keck Hospitals for USC and McLean Hospital for Harvard Medical School where multiple studies are either in process or going through IRB.  Using these results, staff at Rancho, under the supervision of Dr. Charles Liu,  plan to assist with developing cinical protocols for treating multiple conditions including Parkinson’s, Stroke, Concussion and Dementia/MCI.  

See More: Research Papers

Chief - Charles Y. Liu, PhD, MD

Professor, Neurosurgery, Neurology, and Biomedical Engineering USC Director, USC Neurorestoration Center
“SMARTfit is unique in that endless combinations of cognitive and physical challenges can be presented to each user.  Furthermore, IT and big-data ecosystem allows not only tracking of individual progress, but machine-learning and AI algorithms can be applied to fully quantify the neurological phenotype of entire populations and sub-populations and predict the effect of parallel training paradigms on SMARTfit. In this way, the individual expertise of human virtuosos involved in therapy can be scaled up in almost limitless ways.  The applications are of course endless, from neurorestoration to maintenance of wellness. We have a series of validation studies already in process or planned to start in the near future.  These include: Quantifying the neurological phenotype; Parkinson’s; Stroke Rehab; and Dementia.”

Martin Teicher, MD, PhD

McLean Hospital: Director, Developmental Biopsychiatry Research Program. Harvard Medical School: Associate Professor of Psychiatry

“SMARTfit is an exciting technology and I’m looking forward to being part of its validation, where I expect to see the assessment as the treatment and the treatment the assessment.”

Beth Fisher, PhD, PT, FAPTA

Professor of Clinical Physical Therapy Director, Neuroplasticity and Imaging Laboratory Division of Biokinesiology and Physical Therapy, University of Southern California

“Everything in Parkinson’s research points to the need for combining cognitive challenges with physical activities – I cannot think of a better way to do that than with SMARTfit.”

Christopher Powers, PhD, PT, FACSM, FAPTA

USC professor, Director, Biokinesiology Program, Co-Director, Biomechanics Research Lab

“SMARTfit takes the focus of the player off the mechanics and moves it to the external, forcing the brain to solve two problems at the same time. This solves the big missing part in rehab because we want carryover onto the field. SMARTfit is a great tool to test if this is happening before they return to play.”

Fabio Macciardi, MD, PhD

UC Irvine Professor, Laboratory of Molecular Psychiatry, Psychiatry & Human Behavior School of Medicine

“I think that positioning SMARTfit as a key medical device will potentially open up many applications. In particular, I am very interested in exploring applications to promote the rehabilitation of children with motor and cognitive impairments.

This will definitely require some thoughts to first move forward with the easiest applications and then with a more inte-grated plan, when there will be a better understanding of the uncountable developments that SMARTfit allows.”

Phillip D. Tomporowski, PhD

University of Georgia Professor, Department of Kinesiology (Exercise Science Programs)
Translate »